tiprankstipranks
Trending News
More News >
American Bio Medica Corporation (ABMC)
:ABMC
US Market

American Bio Medica (ABMC) Income Statement

Compare
21 Followers

American Bio Medica Income Statement

Last quarter (Q3 2023), American Bio Medica's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, American Bio Medica's net income was $0.00. See American Bio Medica’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 913.00K$ 2.22M$ 4.15M$ 3.65M$ 3.87M
Gross Profit
$ -193.00K$ 548.00K$ 1.24M$ 1.18M$ 1.29M
Operating Expenses
$ 1.05M$ 1.73M$ 1.86M$ 1.78M$ 2.05M
Depreciation and Amortization
$ 51.00K$ 68.00K$ 79.00K$ 81.00K$ 81.00K
EBITDA
$ -1.16M$ -199.00K$ -540.00K$ -340.00K$ -661.00K
Operating Income
$ -1.24M$ -1.18M$ -621.00K$ -593.00K$ -762.00K
Other Income/Expenses
$ -166.00K$ 718.00K$ -173.00K$ -93.00K$ -264.00K
Pretax Income
$ -1.41M$ -461.00K$ -794.00K$ -686.00K$ -1.03M
Net Income
$ -1.41M$ -463.00K$ -796.00K$ -681.00K$ -1.03M
Per Share Metrics
Basic EPS
$ -0.03$ -0.01$ -0.02$ -0.02$ -0.03
Diluted EPS
$ -0.03$ -0.01$ -0.02$ -0.02$ -0.03
Weighted Average Shares Outstanding
48.02M 42.76M 35.56M 32.53M 30.12M
Weighted Average Shares Outstanding (Diluted)
48.02M 42.76M 35.56M 32.53M 30.12M
Currency in USD

American Bio Medica Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis